Pre-earnings options volume in Mineralys Therapeutics (MLYS) Inc is normal with calls leading puts 6:1. Implied volatility suggests the market is anticipating a move near 13.2%, or 0c, after results are released. Median move over the past eight quarters is 4.2%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- Mineralys Therapeutics Inc call volume above normal and directionally bullish
- Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch
- Mineralys Therapeutics: Lorundrostat’s Broad Efficacy, Favorable Safety, and Upside Indications Support Buy Rating on MLYS
- Mineralys updates lorundrostat program and upcoming data milestones
- Mineralys Therapeutics provides corporate update